Diamyd Medical AB (DYMDF)
0.73
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Diamyd Medical Net Income (Quarterly) : -13.67M for May 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -13.67M |
| February 28, 2026 | -6.879M |
| November 30, 2025 | -5.177M |
| August 31, 2025 | -4.683M |
| May 31, 2025 | -4.455M |
| February 28, 2025 | -4.095M |
| November 30, 2024 | -3.436M |
| August 31, 2024 | -4.734M |
| May 31, 2024 | -3.757M |
| February 29, 2024 | -2.825M |
| November 30, 2023 | -3.000M |
| August 31, 2023 | -2.020M |
| May 31, 2023 | -1.977M |
| February 28, 2023 | -2.398M |
| November 30, 2022 | -3.027M |
| August 31, 2022 | -3.581M |
| May 31, 2022 | -1.766M |
| February 28, 2022 | -0.9798M |
| November 30, 2021 | -4.339M |
| August 31, 2021 | -3.197M |
| May 31, 2021 | -3.859M |
| February 28, 2021 | 1.805M |
| November 30, 2020 | 11.96M |
| August 31, 2020 | -1.494M |
| May 31, 2020 | -0.7259M |
| Date | Value |
|---|---|
| February 29, 2020 | 3.891M |
| November 30, 2019 | -0.6985M |
| August 31, 2019 | -1.029M |
| May 31, 2019 | -0.8384M |
| February 28, 2019 | -1.147M |
| November 30, 2018 | -0.9449M |
| August 31, 2018 | -1.316M |
| May 31, 2018 | -1.477M |
| February 28, 2018 | -1.124M |
| November 30, 2017 | -1.315M |
| August 31, 2017 | -0.7772M |
| May 31, 2017 | -0.9354M |
| February 28, 2017 | -0.7108M |
| November 30, 2016 | -0.4916M |
| August 31, 2016 | -0.5678M |
| May 31, 2016 | -2.215M |
| February 29, 2016 | -0.5513M |
| November 30, 2015 | -0.5086M |
| August 31, 2015 | -0.5066M |
| May 31, 2015 | -0.8525M |
| February 28, 2015 | -0.5074M |
| November 30, 2014 | -0.813M |
| August 31, 2014 | -0.4788M |
| May 31, 2014 | -0.5488M |
| February 28, 2014 | -0.6746M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hansa Biopharma AB | -27.82M |
| BioArctic AB | -1.193M |
| Swedish Orphan Biovitrum AB | 117.25M |
| BONESUPPORT HOLDING AB | 8.743M |
| BioInvent International AB | -13.12M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0074M |
| Total Expenses (Quarterly) | 13.68M |
| EPS Diluted (Quarterly) | -0.0909 |
| Enterprise Value | 81.42M |
| Gross Profit Margin (Quarterly) | -32.07K% |
| Profit Margin (Quarterly) | -184.8K% |
| Earnings Yield | -29.12% |
| Normalized Earnings Yield | -29.03 |